Vitamin D and aging: old concepts and new insights.
暂无分享,去创建一个
[1] B. Diffey,et al. Subliminal ultraviolet‐B irradiation for the prevention of vitamin D deficiency in the elderly: a feasibility study , 2001, Photodermatology, photoimmunology & photomedicine.
[2] H. DeLuca,et al. Regulation of 25-hydroxyvitamin D3 1alpha-hydroxylase gene expression by parathyroid hormone and 1,25-dihydroxyvitamin D3. , 2000, Archives of biochemistry and biophysics.
[3] R. Baron,et al. Targeted ablation of the vitamin D receptor: an animal model of vitamin D-dependent rickets type II with alopecia. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[4] R. Baron,et al. Rescue of the Skeletal Phenotype of Vitamin D Receptor-Ablated Mice in the Setting of Normal Mineral Ion Homeostasis: Formal Histomorphometric and Biomechanical Analyses1. , 1999, Endocrinology.
[5] C. Hoppel,et al. Oxidative phosphorylation and aging , 2006, Ageing Research Reviews.
[6] T. Meitinger,et al. Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23 , 2000, Nature Genetics.
[7] F. Oppenheimer,et al. Uremic tumoral calcinosis in patients receiving longterm hemodialysis therapy. , 1999, The Journal of rheumatology.
[8] M. Holick,et al. AGE, VITAMIN D, AND SOLAR ULTRAVIOLET , 1989, The Lancet.
[9] M. Razzaque,et al. Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice. , 2004, Matrix biology : journal of the International Society for Matrix Biology.
[10] L. Mosekilde. Vitamin D and the elderly , 2005, Clinical endocrinology.
[11] G. Åkerström,et al. 25-hydroxyvitamin D(3)-1alpha-hydroxylase expression in normal and pathological parathyroid glands. , 2002, The Journal of clinical endocrinology and metabolism.
[12] Tadashi Kaname,et al. Mutation of the mouse klotho gene leads to a syndrome resembling ageing , 1997, Nature.
[13] S. Reid,et al. On the ontogeny and interactions of phosphofructokinase in mouse tissues. , 1986, The International journal of biochemistry.
[14] P. Orlik,et al. An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia. , 2005, Human molecular genetics.
[15] M. Razzaque,et al. Hypervitaminosis D and premature aging: lessons learned from Fgf23 and Klotho mutant mice. , 2006, Trends in molecular medicine.
[16] M. Razzaque,et al. Premature aging in klotho mutant mice: Cause or consequence? , 2007, Ageing Research Reviews.
[17] L. Bouter,et al. Vitamin D Supplementation and Fracture Incidence in Elderly Persons , 1996, Annals of Internal Medicine.
[18] D. Arking,et al. Association Between a Functional Variant of the KLOTHO Gene and High-Density Lipoprotein Cholesterol, Blood Pressure, Stroke, and Longevity , 2005, Circulation research.
[19] I. Holm,et al. Hypervitaminosis D associated with drinking milk. , 1992, The New England journal of medicine.
[20] Tatsuya Yoshizawa,et al. Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning , 1997, Nature Genetics.
[21] M. Razzaque,et al. Life-long suppression of growth hormone-insulin-like growth factor I activity in genetically altered rats could prevent age-related renal damage. , 2006, Endocrinology.
[22] M. Razzaque,et al. FGF-23, vitamin D and calcification: the unholy triad. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[23] H. Pols,et al. Vitamin D , 1928, Calcified Tissue International.
[24] R. Baron,et al. Printed in U.S.A. Copyright © 1999 by The Endocrine Society Rescue of the Skeletal Phenotype of Vitamin D Receptor- Ablated Mice in the Setting of Normal Mineral Ion , 2022 .
[25] Torben A. Kruse,et al. Design and analysis in genetic studies of human ageing and longevity , 2006, Ageing Research Reviews.
[26] M. Kuro-o,et al. Disease model: human aging. , 2001, Trends in molecular medicine.
[27] J. Manson,et al. Calcium plus vitamin D supplementation and the risk of fractures. , 2006, The New England journal of medicine.
[28] M. Kuro-o. Klotho as a regulator of fibroblast growth factor signaling and phosphate/calcium metabolism , 2006, Current opinion in nephrology and hypertension.
[29] E. Harju,et al. Annual injection of vitamin D and fractures of aged bones , 1992, Calcified Tissue International.
[30] M. Razzaque,et al. Premature aging‐like phenotype in fibroblast growth factor 23 null mice is a vitamin D‐mediated process , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[31] M. Razzaque,et al. Genetic ablation of vitamin D activation pathway reverses biochemical and skeletal anomalies in Fgf-23-null animals. , 2006, The American journal of pathology.
[32] T. Chen,et al. Vitamin D intoxication associated with an over-the-counter supplement. , 2001, The New England journal of medicine.
[33] Andrew Scutt,et al. Aging of mesenchymal stem cells , 2006, Ageing Research Reviews.
[34] K. Fukuda,et al. Klotho, a gene related to a syndrome resembling human premature aging, functions in a negative regulatory circuit of vitamin D endocrine system. , 2003, Molecular endocrinology.
[35] Y. Nabeshima. Klotho: a fundamental regulator of aging , 2002, Ageing Research Reviews.
[36] Y. Takeuchi,et al. Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. , 2004, The Journal of clinical investigation.
[37] John Adams,et al. Gains in Bone Mineral Density with Resolution of Vitamin D Intoxication , 1997, Annals of Internal Medicine.
[38] Olivier Dardenne,et al. Targeted Inactivation of the 25-Hydroxyvitamin D3-1α-Hydroxylase Gene (CYP27B1) Creates an Animal Model of Pseudovitamin D-Deficiency Rickets. , 2001, Endocrinology.
[39] G. Åkerström,et al. 25-hydroxyvitamin D3-1α-hydroxylase expression in normal and pathological parathyroid glands , 2002 .
[40] R. Doll,et al. Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial , 2003, BMJ : British Medical Journal.
[41] S. Ginsberg,et al. Expression profiling in the aging brain: A perspective , 2005, Ageing Research Reviews.
[42] M. Pahor,et al. Mitochondrial DNA mutations, energy metabolism and apoptosis in aging muscle , 2006, Ageing Research Reviews.
[43] G. Eknoyan,et al. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[44] H. Faure,et al. Physical activity alters antioxidant status in exercising elderly subjects. , 2006, The Journal of nutritional biochemistry.
[45] P. Lips,et al. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. , 2001, Endocrine reviews.
[46] P. Ureña,et al. Recent findings in phosphate homeostasis , 2005, Current opinion in nephrology and hypertension.
[47] N. Amizuka,et al. Targeted inactivation of Npt2 in mice leads to severe renal phosphate wasting, hypercalciuria, and skeletal abnormalities. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[48] G E Dallal,et al. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. , 1997, The New England journal of medicine.
[49] J. Goff,et al. Calcium and Vitamin D Metabolism During Lactation , 1997, Journal of Mammary Gland Biology and Neoplasia.
[50] Dongxu Sun,et al. Effect of fish oil on bone mineral density in aging C57BL/6 female mice. , 2007, The Journal of nutritional biochemistry.
[51] F. Glorieux,et al. Targeted inactivation of the 25-hydroxyvitamin D(3)-1(alpha)-hydroxylase gene (CYP27B1) creates an animal model of pseudovitamin D-deficiency rickets. , 2001, Endocrinology.
[52] F. Glorieux,et al. Correction of the abnormal mineral ion homeostasis with a high-calcium, high-phosphorus, high-lactose diet rescues the PDDR phenotype of mice deficient for the 25-hydroxyvitamin D-1alpha-hydroxylase (CYP27B1). , 2003, Bone.
[53] Y. Frishberg,et al. Hyperostosis–Hyperphosphatemia Syndrome: A Congenital Disorder of O‐Glycosylation Associated With Augmented Processing of Fibroblast Growth Factor 23 , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[54] H. DeLuca,et al. Expression of 1,25-dihydroxyvitamin D(3) receptor in the immune system. , 2000, Archives of biochemistry and biophysics.
[55] A. Zinsmeister,et al. Soft tissue calcification in pediatric patients with end-stage renal disease , 1991, Pediatric Nephrology.
[56] N. Seyahi,et al. Intracranial calcification and tumoural calcinosis during vitamin D therapy , 2004, Nephrology.
[57] M. Fukagawa,et al. Role of fibroblast growth factor 23 in health and in chronic kidney disease , 2005, Current opinion in nephrology and hypertension.